LD-2 disclosure · 4th Quarter - Report
BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
via BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
Client
- Name
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Location
- District of Columbia · United States of America
Registrant
- Firm
- BREAKTHROUGH T1D (FORMERLY KNOWN AS JDRF INTL.)
- Description
- Charitable funder of diabetes research
- Location
- WASHINGTON, District of Columbia, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to prescription drug pricing, particularly as it relates to insulin S. 4446, Modernizing the Accelerated Approval Pathway Act of 2022 H.R. 6963, Accelerated Approval Integrity Act of 2022 H.R. 4128/S. 2209, VALID Act of 2021
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
S. 4808, Enhancing American Retirement (EARN) Act S. 243, Legacy IRA Act
LobbyistsLAURA WHITTON
TargetedSENATE · HOUSE OF REPRESENTATIVES
Budget/Appropriations
H.R. 2617, the Consolidated Appropriations Act, 2023 Issues related to HHS/NIH/FDA funding
LobbyistsLAURA WHITTON · NIELS KNUTSON · PEDRO MONTENEGRO
TargetedSENATE · HOUSE OF REPRESENTATIVES